WASHINGTON, D.C. — Federal health officials this week announced a sweeping series of actions ranging from new drug approval guidance and Medicare fraud enforcement to more than $1 billion in farm modernization investments and new appointments to a key vaccine advisory panel.
What This Means for You
- FDA is proposing a faster approval pathway for highly individualized therapies for ultra-rare diseases.
- Medicare and Medicaid fraud enforcement is shifting toward real-time detection, including a $259.5 million Medicaid funding deferral in Minnesota.
- More than $1 billion in federal funding is being directed toward regenerative agriculture, chemical exposure research, and farm modernization.
FDA Draft Guidance for Ultra-Rare Diseases
The Food and Drug Administration on February 23 issued draft guidance outlining how sponsors can seek full approval of targeted individualized therapies when traditional large clinical trials are not feasible due to small patient populations.
The guidance applies to therapies that directly target a specific genetic, cellular, or molecular abnormality and are designed to correct or modify the underlying cause of disease. It discusses genome editing and RNA-based therapies, including antisense oligonucleotides — short strands of synthetic genetic material designed to alter gene expression.
Under the proposed framework, sponsors would need to identify the disease-causing abnormality, demonstrate that the therapy targets the root cause or related biological pathway, rely on well-characterized data from untreated patients, and confirm that the therapy successfully edits or targets the intended mechanism. For traditional approval, the agency said therapies should demonstrate improvements in clinical outcomes, disease progression, or validated biomarkers.
The draft guidance is open for public comment for 60 days after publication in the Federal Register at Regulations.gov.
Medicare and Medicaid Fraud Actions
On February 25, Vice President J.D. Vance, Health and Human Services Secretary Robert F. Kennedy Jr., and Centers for Medicare & Medicaid Services Administrator Dr. Mehmet Oz announced new fraud prevention steps.
Those steps include deferring $259.5 million in quarterly federal Medicaid funding in Minnesota while further investigation of certain claims is completed; imposing a nationwide moratorium on Medicare enrollment for certain Durable Medical Equipment, Prosthetics, Orthotics, and Supplies suppliers; and launching a nationwide call to action under the Comprehensive Regulations to Uncover Suspicious Healthcare initiative, known as CRUSH.
Durable Medical Equipment, Prosthetics, Orthotics, and Supplies, or DMEPOS, refers to items such as wheelchairs, braces, oxygen equipment, and other medical supplies used in home care.
Kennedy said the department is shifting from what he described as a “pay and chase” model — in which improper payments are pursued after the fact — to a “detect and deploy” strategy using artificial intelligence tools to identify suspected fraud before payments are made.
More information on CMS fraud prevention efforts is available at cms.gov/fraud.
$1 Billion for Farm Modernization and Food Security
On February 27, HHS, the U.S. Department of Agriculture, and the Environmental Protection Agency announced more than $1 billion in investments tied to farm modernization and long-term food supply security.
The plan follows Executive Order 14212 establishing the Make America Healthy Again Commission and directs agencies to work with farmers to improve food security and agricultural resilience.
The initiative includes $840 million from USDA, including $400 million through the Environmental Quality Incentives Program and $300 million through the Conservation Stewardship Program to support regenerative agriculture practices in fiscal year 2026. Regenerative agriculture refers to farming methods aimed at improving soil health, water quality, and ecosystem resilience.
An additional $140 million will support the Strengthening Agricultural Systems Program to address large-scale agricultural challenges, including pests, plant and animal diseases, and food-related chronic disease.
HHS is contributing $200 million, including a $100 million National Institutes of Health grand prize challenge focused on evaluating cumulative chemical exposures and a $100 million Advanced Research Projects Agency for Health initiative to develop alternatives to chemical crop protection tools.
The EPA announced a $30 million grand prize challenge for alternatives to pre-harvest pesticide use.
“Take Back Your Health” Tour in Texas
Secretary Kennedy continued his “Take Back Your Health” tour in Austin, headlining an “Eat Real Food” rally and visiting Cunningham Elementary School in the Austin Independent School District.
At the rally, Kennedy promoted updated Dietary Guidelines for Americans and emphasized nutrient-dense foods. At Cunningham Elementary, he toured the cafeteria and teaching kitchen, observed scratch-cooking practices, and served food to students.
While in Austin, Kennedy also recorded podcast interviews discussing chronic disease prevention and food policy.
New CDC Immunization Advisory Members
Also on February 27, HHS and the Centers for Disease Control and Prevention announced the appointment of two new members to the CDC Advisory Committee on Immunization Practices, known as ACIP.
ACIP advises the CDC Director and HHS Secretary on the use of vaccines to control vaccine-preventable diseases in the civilian population.
The new appointees are Dr. Sean G. Downing, a physician specializing in internal medicine and pediatrics, and Dr. Angelina Farella, a pediatrician and private practice owner in Texas.
HHS said the appointments follow the reconstitution of ACIP in June 2025 and are intended to strengthen clinical expertise and transparency in vaccine policy deliberations.
For the latest news on everything happening in Chester County and the surrounding area, be sure to follow MyChesCo on Google News and MSN.